EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Chinese Herbal Medicines for Diabetic Cardio‐Cerebrovascular Diseases: Key Bioactive Metabolites and Action Mechanisms

Ying Su, Shuwen Luo, Wei Li, Cuicui Cheng, Wei Liu, Xinyu Yang iD, Zhen Xing iD

Journal of Nutrition and Metabolism · 2026-01 · 2026 (1)

DOI: 10.1155/jnme/5563248 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Nutrition and Metabolism, online erschienen am 24.02.2026. Verfasst von Ying Su und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, Dongping People's Hospital, Taian, 271500, Shandong, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 203 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Currently, the global incidence of diabetes is increasing, particularly in populous developing regions. In China, over 290 million people are affected by diabetic cardio‐cerebrovascular diseases. These diseases account for more than 40% of deaths and impose a significant economic burden on both society and families. Diabetes can result in vascular complications through multiple mechanisms, including cardiovascular and cerebrovascular diseases. Current management guidelines recommend conducting risk assessments before prescribing medications like antihypertensives, hypoglycemics, and lipid‐lowering drugs, alongside lifestyle interventions, to help prevent cardio‐cerebrovascular diseases. However, pharmacological approaches have several limitations, including adverse drug reactions and variability in patient responses. Chinese herbal medicine (CHM) exerts its therapeutic effects via bioactive metabolites that modulate multiple molecular targets, including enzymes, receptors, and transcriptional regulators, through complex interactions with cellular signaling networks. While modern pharmacological research validates its polypharmacological mechanisms, concerns persist regarding potential botanical drug interactions, toxicological profiles, and pharmacokinetic variability of certain botanicals. Only through a balanced scientific approach can CHM’s unique therapeutic value be fully realized. This review evaluates the efficacy of CHM in mitigating metabolic disorders, focusing on its diverse pharmacological mechanisms, including antioxidant defenses, inflammation suppression, and programmed cell death regulation. It elucidates the role of pivotal signaling cascades, including the glucagon (GLC)/5′‐adenosine monophosphate–activated protein kinase (AMPK)/nuclear transcription factor‐κB (NF‐κB) axis, the GLC/peroxisome proliferator–activated receptor α (PPARα)/PGC‐1α pathway, as well as the PI3K/Akt and AMPK/mammalian target of rapamycin (mTOR) signaling pathway, alongside oxidative stress and inflammatory responses. However, future research should prioritize well‐structured clinical trials and mechanistic studies to substantiate CHM’s therapeutic potential.

Schlagwörter

Stichwörter der Autor:innen

Chinese herbal medicineapoptosisdiabetic cardio-cerebrovascular diseaseinflammationmitochondriaoxidative stress

Autor:innen und Institutionen

  • Department of Traditional Chinese Medicine, Dongping People's Hospital, Taian, 271500, Shandong, China.
  • Department of Traditional Chinese Medicine, Hainan Province Anning Hospital, Haikou, 572299, Hainan, China.
  • Linhe Kangyou Hospital, Bayannur, 015099, Inner Mongolia, China.
  • Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical, Beijing, 100700, China.
  • Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, 100078, China, bucm.edu.cn.

ORCID-Profile: Xinyu Yang, Zhen Xing

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Su, Y., Luo, S., Li, W., Cheng, C., Liu, W., Yang, X., & Xing, Z. (2026). Chinese Herbal Medicines for Diabetic Cardio‐Cerebrovascular Diseases: Key Bioactive Metabolites and Action Mechanisms. Journal of Nutrition and Metabolism, 2026(1). https://doi.org/10.1155/jnme/5563248

Vancouver

Su Y, Luo S, Li W, Cheng C, Liu W, Yang X, et al. Chinese Herbal Medicines for Diabetic Cardio‐Cerebrovascular Diseases: Key Bioactive Metabolites and Action Mechanisms. Journal of Nutrition and Metabolism. 2026;2026(1). doi:10.1155/jnme/5563248

BibTeX
@article{Su2026,
  author = {Su, Ying and Luo, Shuwen and Li, Wei and Cheng, Cuicui and Liu, Wei and Yang, Xinyu and Xing, Zhen},
  title = {Chinese Herbal Medicines for Diabetic Cardio‐Cerebrovascular Diseases: Key Bioactive Metabolites and Action Mechanisms},
  journal = {Journal of Nutrition and Metabolism},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/jnme/5563248}
}
Kostenlos starten →